Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy

被引：0
|
作者：
Hu, Qiongjie [1 ,3 ]
Shi, Yueli [1 ,2 ]
Wang, Huang [4 ]
Bing, Liuwen [3 ]
Xu, Zhiyong [1 ,2 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 4, Dept Resp & Crit Care Med, Yiwu 322000, Zhejiang, Peoples R China
[2] Zhejiang Key Lab Precis Diag & Treatment Lung Canc, Yiwu 322000, Peoples R China
[3] Zhejiang Chinese Med Univ, Affiliated Hosp 3, Hangzhou 310013, Peoples R China
[4] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Nanjing, Peoples R China
来源：
EXPERIMENTAL HEMATOLOGY & ONCOLOGY | 2025年 / 14卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Cancer immunotherapy; Immune checkpoint blockade; Post-translational modifications; Ubiquitination; Phosphorylation; ANTIBODY-BASED PROTACS; CELL LUNG-CANCER; SIRP-ALPHA; TUMOR MICROENVIRONMENT; PD-L1; EXPRESSION; BREAST-CANCER; T-CELLS; COINHIBITORY PATHWAYS; REGULATES ANTITUMOR; ACQUIRED-RESISTANCE;
D O I：
10.1186/s40164-025-00627-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Immunotherapy targeting immune checkpoints has gained traction across various cancer types in clinical settings due to its notable advantages. Despite this, the overall response rates among patients remain modest, alongside issues of drug resistance and adverse effects. Hence, there is a pressing need to enhance immune checkpoint blockade (ICB) therapies. Post-translational modifications (PTMs) are crucial for protein functionality. Recent research emphasizes their pivotal role in immune checkpoint regulation, directly impacting the expression and function of these key proteins. This review delves into the influence of significant PTMs-ubiquitination, phosphorylation, and glycosylation-on immune checkpoint signaling. By targeting these modifications, novel immunotherapeutic strategies have emerged, paving the way for advancements in optimizing immune checkpoint blockade therapies in the future.
引用
收藏
页数：28
相关论文
共 50 条
  • [21] Unconventional protein post-translational modifications: the helmsmen in breast cancer
    Jiena Liu
    Qin Wang
    Yujuan Kang
    Shouping Xu
    Da Pang
    Cell & Bioscience, 12
  • [22] Post-translational modifications of EMT transcriptional factors in cancer metastasis
    Chang, Rui
    Zhang, Peng
    You, Jiacong
    OPEN LIFE SCIENCES, 2016, 11 (01): : 237 - 243
  • [23] Epigenetic Regulation and Post-Translational Modifications of SNAI1 in Cancer Metastasis
    Dong, Bo
    Wu, Yadi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (20)
  • [24] Post-translational modifications of exosomal proteins
    Moreno-Gonzalo, Olga
    Villarroya-Beltri, Carolina
    Sanchez-Madrid, Francisco
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [25] Post-translational modifications of the polycystin proteins
    Streets, Andrew
    Ong, Albert
    CELLULAR SIGNALLING, 2020, 72
  • [26] Unconventional protein post-translational modifications: the helmsmen in breast cancer
    Liu, Jiena
    Wang, Qin
    Kang, Yujuan
    Xu, Shouping
    Pang, Da
    CELL AND BIOSCIENCE, 2022, 12 (01)
  • [27] The Post-translational Modifications of Smurf2 in TGF-β Signaling
    Bai, Yangjinming
    Ying, Ying
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [28] Post-Translational Modifications and RNA-Binding Proteins
    Lovci, Michael T.
    Bengtson, Mario H.
    Massirer, Katlin B.
    RNA PROCESSING: DISEASE AND GENOME-WIDE PROBING, 2016, 907 : 297 - 317
  • [29] Post-translational Modifications of IκBα: The State of the Art
    Wang, Xiuli
    Peng, Hanlin
    Huang, Yaqian
    Kong, Wei
    Cui, Qinghua
    Du, Junbao
    Jin, Hongfang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [30] Post-translational modifications of the progesterone receptors
    Abdel-Hafiz, Hany A.
    Horwitz, Kathryn B.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2014, 140 : 80 - 89
12345